1. Home
  2. OCS vs WGO Comparison

OCS vs WGO Comparison

Compare OCS & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • WGO
  • Stock Information
  • Founded
  • OCS 2003
  • WGO 1958
  • Country
  • OCS Switzerland
  • WGO United States
  • Employees
  • OCS N/A
  • WGO N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • WGO Homebuilding
  • Sector
  • OCS Health Care
  • WGO Industrials
  • Exchange
  • OCS Nasdaq
  • WGO Nasdaq
  • Market Cap
  • OCS 956.4M
  • WGO 893.6M
  • IPO Year
  • OCS N/A
  • WGO N/A
  • Fundamental
  • Price
  • OCS $17.34
  • WGO $33.49
  • Analyst Decision
  • OCS Strong Buy
  • WGO Buy
  • Analyst Count
  • OCS 4
  • WGO 11
  • Target Price
  • OCS $35.75
  • WGO $40.10
  • AVG Volume (30 Days)
  • OCS 14.2K
  • WGO 462.1K
  • Earning Date
  • OCS 11-06-2025
  • WGO 10-22-2025
  • Dividend Yield
  • OCS N/A
  • WGO 4.07%
  • EPS Growth
  • OCS N/A
  • WGO N/A
  • EPS
  • OCS N/A
  • WGO N/A
  • Revenue
  • OCS $960,668.00
  • WGO $2,741,800,000.00
  • Revenue This Year
  • OCS $11.49
  • WGO N/A
  • Revenue Next Year
  • OCS $1,784.02
  • WGO $5.92
  • P/E Ratio
  • OCS N/A
  • WGO N/A
  • Revenue Growth
  • OCS N/A
  • WGO N/A
  • 52 Week Low
  • OCS $11.78
  • WGO $28.00
  • 52 Week High
  • OCS $23.08
  • WGO $65.65
  • Technical
  • Relative Strength Index (RSI)
  • OCS 48.91
  • WGO 45.57
  • Support Level
  • OCS $16.94
  • WGO $33.81
  • Resistance Level
  • OCS $17.34
  • WGO $35.28
  • Average True Range (ATR)
  • OCS 0.40
  • WGO 1.15
  • MACD
  • OCS 0.08
  • WGO -0.40
  • Stochastic Oscillator
  • OCS 73.35
  • WGO 8.32

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About WGO Winnebago Industries Inc.

Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.

Share on Social Networks: